These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 2615857
1. 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors. Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, Grifantini M. Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):679-83. PubMed ID: 2615857 [Abstract] [Full Text] [Related]
2. 2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Lohse MJ, Klotz KN, Schwabe U, Cristalli G, Vittori S, Grifantini M. Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):687-9. PubMed ID: 3216901 [Abstract] [Full Text] [Related]
5. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes. Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S. Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729 [Abstract] [Full Text] [Related]
6. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP, Curtis AR, Kendall DA, Hill SJ. Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308 [Abstract] [Full Text] [Related]
7. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M. J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819 [Abstract] [Full Text] [Related]
8. Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex. Jarvis MF, Williams M, Do UH, Sills MA. Mol Pharmacol; 1991 Jan; 39(1):49-54. PubMed ID: 1987452 [Abstract] [Full Text] [Related]
9. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP. Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787 [Abstract] [Full Text] [Related]
11. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Bruns RF, Lu GH, Pugsley TA. Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074 [Abstract] [Full Text] [Related]
12. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine. Monopoli A, Conti A, Dionisotti S, Casati C, Camaioni E, Cristalli G, Ongini E. Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348 [Abstract] [Full Text] [Related]
13. Affinity of central adenosine A1 receptors is decreased in spontaneously hypertensive rats. Matias A, Zimmer FJ, Lorenzen A, Keil R, Schwabe U. Eur J Pharmacol; 1993 Feb 15; 244(3):223-30. PubMed ID: 8458399 [Abstract] [Full Text] [Related]
17. Identification of A1 and A2 adenosine receptors in the rat spinal cord. Choca JI, Proudfit HK, Green RD. J Pharmacol Exp Ther; 1987 Sep 15; 242(3):905-10. PubMed ID: 3656118 [Abstract] [Full Text] [Related]